Winner Medical Co., Ltd. (SHE:300888)
China · Delayed Price · Currency is CNY 29.69
-0.24 (-0.80%)
Oct 28, 2026, 9:45 AM CST
Winner Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 11,162 | 10,863 | 8,896 | 8,124 | 11,258 | 7,976 |
Other Revenue | 86.21 | 86.21 | 81.38 | 60.7 | 93.58 | 61.2 |
| 11,248 | 10,949 | 8,978 | 8,185 | 11,351 | 8,037 | |
Revenue Growth | 4.10% | 21.96% | 9.69% | -27.89% | 41.23% | -35.88% |
Cost of Revenue | 5,984 | 5,809 | 4,880 | 4,393 | 6,340 | 4,121 |
Gross Profit | 5,264 | 5,140 | 4,098 | 3,792 | 5,011 | 3,916 |
Selling, General & Admin | 3,542 | 3,479 | 2,931 | 2,756 | 2,649 | 2,444 |
Research & Development | 422.61 | 410.88 | 348.16 | 322.05 | 487.58 | 298.16 |
Other Operating Expenses | 82.76 | 53.64 | 26.2 | 39.96 | 98.09 | 65.39 |
Operating Expenses | 4,048 | 3,954 | 3,307 | 3,115 | 3,229 | 2,804 |
Operating Income | 1,216 | 1,187 | 790.81 | 677.12 | 1,782 | 1,113 |
Interest Expense | -35.23 | -55.11 | -54.86 | -63.44 | -50.04 | -29.99 |
Interest & Investment Income | 118.81 | 135.49 | 192.48 | 261.26 | 175.38 | 240.42 |
Currency Exchange Gain (Loss) | -28.61 | -28.61 | 40.19 | -7.63 | 52.07 | 0.61 |
Other Non Operating Income (Expenses) | -92.39 | -5.99 | -1.2 | 0.68 | -72.25 | -4.27 |
EBT Excluding Unusual Items | 1,178 | 1,232 | 967.43 | 867.99 | 1,887 | 1,319 |
Impairment of Goodwill | -179.04 | -179.04 | -90.74 | -188.79 | - | - |
Gain (Loss) on Sale of Investments | -8.06 | -24.34 | 2.86 | 46.68 | 32.15 | 58.47 |
Gain (Loss) on Sale of Assets | 0.66 | 0.55 | 5.88 | 32.2 | 3.73 | 3.25 |
Asset Writedown | -13.15 | -19.28 | -16.45 | -93.43 | -74.78 | -20.26 |
Other Unusual Items | 37.44 | 37.44 | 39.38 | 85.19 | 71.05 | 101.8 |
Pretax Income | 1,016 | 1,048 | 908.35 | 749.85 | 1,920 | 1,463 |
Income Tax Expense | 192.23 | 233.7 | 167.64 | 121.3 | 245.17 | 225.32 |
Earnings From Continuing Operations | 823.87 | 814.12 | 740.71 | 628.55 | 1,674 | 1,237 |
Minority Interest in Earnings | -46.91 | -46.15 | -45.33 | -48.14 | -23.62 | 1.88 |
Net Income | 776.96 | 767.97 | 695.38 | 580.4 | 1,651 | 1,239 |
Net Income to Common | 776.96 | 767.97 | 695.38 | 580.4 | 1,651 | 1,239 |
Net Income Growth | -11.13% | 10.44% | 19.81% | -64.84% | 33.20% | -67.47% |
Shares Outstanding (Basic) | 580 | 582 | 584 | 592 | 592 | 596 |
Shares Outstanding (Diluted) | 580 | 582 | 584 | 592 | 592 | 596 |
Shares Change | -0.55% | -0.44% | -1.33% | 0.10% | -0.77% | 9.42% |
EPS (Basic) | 1.34 | 1.32 | 1.19 | 0.98 | 2.79 | 2.08 |
EPS (Diluted) | 1.34 | 1.32 | 1.19 | 0.98 | 2.79 | 2.08 |
EPS Growth | -10.64% | 10.92% | 21.43% | -64.88% | 34.23% | -70.28% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 769.71 | 1,018 | 364.87 | 310.26 | 1,784 | 128.42 |
Free Cash Flow Per Share | 1.33 | 1.75 | 0.62 | 0.52 | 3.02 | 0.21 |
Dividend Per Share | 0.800 | 0.750 | 0.650 | 0.500 | 1.357 | 0.900 |
Dividend Growth | 14.29% | 15.38% | 30.00% | -63.16% | 50.79% | -50.00% |
Gross Margin | 46.80% | 46.95% | 45.65% | 46.33% | 44.15% | 48.73% |
Operating Margin | 10.81% | 10.84% | 8.81% | 8.27% | 15.70% | 13.84% |
Profit Margin | 6.91% | 7.01% | 7.75% | 7.09% | 14.54% | 15.42% |
Free Cash Flow Margin | 6.84% | 9.29% | 4.06% | 3.79% | 15.72% | 1.60% |
EBITDA | 1,694 | 1,613 | 1,147 | 992.8 | 2,049 | 1,279 |
EBITDA Margin | 15.06% | 14.73% | 12.78% | 12.13% | 18.05% | 15.92% |
D&A For EBITDA | 478.44 | 426.11 | 356.32 | 315.68 | 266.49 | 166.69 |
EBIT | 1,216 | 1,187 | 790.81 | 677.12 | 1,782 | 1,113 |
EBIT Margin | 10.81% | 10.84% | 8.81% | 8.27% | 15.70% | 13.84% |
Effective Tax Rate | 18.92% | 22.30% | 18.46% | 16.18% | 12.77% | 15.40% |
Revenue as Reported | 11,248 | 10,949 | 8,978 | 8,185 | 11,351 | 8,037 |
Advertising Expenses | - | 1,093 | 816.38 | 651.82 | 600.16 | 692.45 |